Versarien PLC - Interim Results
Versarien Plc
("Versarien", the "Company" or the "Group")
Interim Results for the six months ended
Versarien Plc (AIM: VRS), the advanced engineering materials group, is pleased to announce its unaudited interim results for the six months ended
Financial Highlights
● Group revenues from continuing operations up 41% to
● Graphene revenues up 166% to
● Adjusted LBITDA** for continuing operations reduced by 39% to
● Reported loss before tax of
● Reported loss before tax from continuing operations of
● Cash of
*Excludes discontinued revenues of
**Adjusted LBITDA (Loss Before Interest, Tax, Depreciation and Amortisation) excludes exceptional items, share-based payment charges and other losses)
Operational Highlights
●
● Acquisition of Spanish graphene manufacturing assets to provide up to an additional 100 tonne powder capacity per annum
● Orders placed for the purchase of equipment to scale up ink production capacity by an additional 12,000 litres per annum
● Lease signed on new dedicated graphene production facility in Longhope,
● Textile supply agreement signed with Crosslete and discussions ongoing with multiple garment suppliers
Post Period Highlights
● Grant agreement signed to support the development of Pseudo-Capacitor technology aimed at zero emissions for port-side infrastructure
● Commercial agreement signed with Superdry to produce graphene enhanced garments
● Royalty agreement signed with Gerdau S.A for the distribution of graphene masks primarily in
"The first half of this financial year has seen continued progress in our pursuit of commercialisation whilst increasing both production capacity and our global footprint. GSCALE remains on track with particularly pleasing results in textiles and concrete. We remain conscious of our environmental obligations which also brings commercial opportunities as we seek to solve some of the global issues and challenges using graphene and allied two dimensional materials"
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE
For further information please contact:
|
Versarien Plc |
|
|
|
+44 (0) 1594 887204 |
|
|
|
|
|
|
|
SP Angel Corporate Finance (Nominated Adviser and Joint Broker) |
|
|
|
+44 (0) 20 3470 0470 |
|
|
|
|
Berenberg (Joint Broker) |
|
|
|
+44 (0) 20 3207 7800 |
|
|
|
|
|
|
|
|
+44 (0) 20 3004 9512 |
Notes to Editors:
The strategy of Versarien Plc (AIM:VRS) is to be a globally recognised graphene company with a wide portfolio of high-quality verified materials allied to the largest relevant IP portfolio supported by its own
For further information please see: http://www.versarien.com
Chairman's Statement
I referred in the annual report to the challenges that Covid-19 had presented, and to the progress that had been made in spite of the restrictions placed upon us. It is therefore extremely pleasing to be able to report continuing progress at the interim stage.
In particular, advancements in both textiles and concrete have been made and the latter brings the opportunity for significant environmental benefits. We are able to deliver on these projects with the continued support of the
Continuing progress means we have to scale up production as demonstrated by the move to dedicated manufacturing facilities in Longhope,
Our global footprint and product portfolio are both important strands of our strategy to become a global player in the graphene space. We have now commissioned all the equipment acquired from Hanwha and have been able to produce high quality CVD single layer graphene suitable for use in the electronics industry.
As announced in
James Stewart CBE
Non-executive Chairman
Chief Executive Officer's Review
As described in the Annual Report, following the focus on graphene and the discontinuance of the aluminium business, segmental analysis is now split between technology and mature operations. The GSCALE project is described in each of the paragraphs below, but in the immediate future management we will be concentrating on the construction and leisure sectors whilst still progressing the described activities.
The technology operations are now located in six countries being
Carbon fibre developments in transport (S) addresses a
1. Mechanical - improved mechanical performance by at least 10% compared to the base prepreg material (fibrous material pre-impregnated with a particular synthetic resin)
2. Visual - Surface quality to meet Lotus' paint specification
3. Price - Achieved a 10% -25% cost reduction
All three objectives were achieved using a hot press production process with lower capital costs and faster manufacturing. Further development will continue as Versarien and Lotus further optimise the process for use in any body panel. Several other projects are ongoing that contribute to further development of enhanced CFRPs for conventional structural supports, which could provide an innovative alternative for automotive, aerospace and rail manufacturers.
The mission for construction (C) is to reduce CO2 emissions. 24.7 million tons of ready mixed concrete is used in the
Opportunities exist in extending asset life by eliminating cracking, using graphene enhanced polypropylene chopped fibres to replace ferrous rebar, development of self healing concrete, faster curing without cracking, non-destructive microwave rapid repair and 3-dimensional printing.
Studies have shown improved compression strength of ~38%, improved flexural strength of between 14% and 45%, increased tensile strength of ~15%, improved water permeability of ~200%, and increased corrosion resistance.
We are working on national highways projects as well as with HS2 for printed concrete and with non-government bodies on flood defences and rail for light quick deployment of flexible design buildings as well as having trademarked Cementene ™ for concrete.
Other project areas include wind turbine bases, building house rafts, water industry, flooring screed, very light rail structures, slipform roads/runways.
The mission for Polymers (A), is to reduce the amount of fossil fuel based plastics required where 3.3 million tonnes of plastic is processed in the
Plastic packaging accounts for 44% of plastic used in the
We continue to work with one of the world's largest packaging companies to evaluate graphene-based coatings as well as on other projects including optical wear, airway medical suction units and other forms of packaging.
The mission for Leisure (L) is similar to polymers, in reducing the use of fossil fuel based materials, but also to improve performance, garment lifetime, recyclability and functionality. In a
As disclosed in the recently announced agreement with Superdry we have developed a number of sample garments which is testament to the benefits of utilising Versarien's graphene technology. We continue to work with many organisations on sportswear, civilian and military clothing as well as in specialist applications such as athletic performance, fire and police.
The mission for Elastomers (E) is to improve performance, extend lifetime, recyclability and functionality in the areas of tyres and rubbers (including footwear). The global footwear market is expected to reach
In footwear we have been able to demonstrate significant increases in tensile strength (~50%), modulus (~30%), elongation (~20%) and tear strength (~23%) when compared to reference non-graphene compounds. We are working with Enso,
The
International Technology Operations
Our international operations are also making progress. In the
In
Gnanomat in
We continue to evaluate the opportunities in
Mature Businesses
Both AAC Cyroma Limited (plastic products) and Total Carbide Limited (hard wear parts) remained operational throughout the Covid-19 pandemic. Last year was challenging but I am pleased to report that sales have increased by 23% over the comparative period and that they have returned to profitability.
We have exited the aluminium business which is shown as discontinued in the financial statements. We continue to examine ways in which both mature businesses can support the technology business in the future and form synergies to improve efficiency.
Current trading and outlook
As of writing, the outlook for the pandemic is far from certain as is the economy, and we remain vigilant around costs. However, the opportunities for graphene both in the
Chief Executive Officer
Chief Financial Officer's review
Group Results
As stated in the annual report, the aluminium business based at
In total, Versarien's revenue for the six months ended
The total loss from operations was
The adjusted LBITDA for continuing operations was
|
|
Six months ended |
Six months ended |
|||||
|
|
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
|
|
|
Continuing operations |
Discontinued operations |
TOTAL |
Continuing operations |
Discontinued operations |
TOTAL |
|
|
Loss from operations |
(2,862) |
(144) |
(3,006) |
(4,254) |
(21) |
(4,275) |
|
|
Depreciation and Amortisation |
683 |
41 |
724 |
504 |
48 |
552 |
|
|
Share based payments |
595 |
- |
595 |
597 |
- |
597 |
|
|
Exceptional items |
41 |
67 |
108 |
178 |
- |
178 |
|
|
Other losses |
830 |
- |
830 |
1,817 |
- |
1,817 |
|
|
Adjusted LBITDA |
(713) |
(36) |
(749) |
(1,158) |
27 |
(1,131) |
|
Exceptional costs were incurred in the period of
Net cash used in operating activities was £1.19 million (H1 2020:
The mature business segment is seeing increased revenues albeit not yet to pre-covid levels and an overall return to profitability. We continue to maintain strict control over costs.
In summary, it is pleasing to report that the Group's financial results are showing revenue recovery, significantly reduced losses and an improvement in cash resources as we continue to focus on expanding our production facilities with our continued focus on GSCALE.
Chief Financial Officer
Consolidated Interim Financial Statements
Group statement of comprehensive income
For the half year ended
|
|
|
30 September 2021 Unaudited £'000 |
30 September 2020 Unaudited £'000 |
|
|
Notes |
|
|
|
Continuing operations |
|
|
|
|
Revenue |
3 |
3,824 |
2,709 |
|
Cost of sales |
|
(2,744) |
(2,310) |
|
Gross profit |
|
1,080 |
399 |
|
Other operating income |
|
88 |
72 |
|
Other losses |
|
(830) |
(1,817) |
|
Operating expenses (including exceptional items) |
|
(3,200) |
(2,908) |
|
Loss from operations before exceptional items |
|
(2,818) |
(4,076) |
|
Exceptional items |
4 |
(44) |
(178) |
|
Loss from operations |
|
(2,862) |
(4,254) |
|
Finance charge |
|
(96) |
(58) |
|
Loss before income tax |
|
(2,958) |
(4,312) |
|
Income Tax |
5 |
- |
- |
|
Loss from continuing operations |
|
(2,958) |
(4,312) |
|
Loss from discontinued operations |
2 |
(155) |
(27) |
|
Loss for the period |
|
(3,113) |
(4,339) |
|
Loss attributable to: |
|
|
|
|
- Owners of the parent company |
|
(3,021) |
(4,158) |
|
- Non-controlling interest |
|
(92) |
(181) |
|
|
|
(3,113) |
(4,339) |
|
Loss per share attributable to the equity holders of the Company: |
|
|
|
|
Basic and diluted loss per share |
6 |
(1.56)p |
(2.45)p |
|
|
|
|
|
There is no other comprehensive income for the year.
The other losses in the period relates to the fair value assessment of the Lanstead sharing agreements at the balance sheet date.
Group statement of financial position
As at
|
|
Note |
30 September 2021 Unaudited £'000 |
31 March 2021 Audited £'000 |
|
Assets |
|
|
|
|
Non-current assets |
|
|
|
|
Intangible Assets |
7 |
10,397 |
9,706 |
|
Property, plant and equipment |
|
4,865 |
4,119 |
|
Deferred taxation |
|
25 |
25 |
|
Trade and other receivables |
|
40 |
772 |
|
|
|
15,327 |
14,622 |
|
Current assets |
|
|
|
|
Inventory |
|
1,666 |
1,814 |
|
Trade and other receivables |
|
4,391 |
6,449 |
|
Cash and cash equivalents |
|
3,462 |
2,359 |
|
|
|
9,519 |
10,622 |
|
Total assets |
|
24,846 |
25,244 |
|
Equity |
|
|
|
|
Called up share capital |
|
1,941 |
1,899 |
|
Share premium |
|
34,864 |
33,003 |
|
Merger reserve |
|
1,256 |
1,256 |
|
Share-based payment reserve |
|
3,844 |
3,249 |
|
Accumulated losses |
|
(24,646) |
(21,625) |
|
Equity attributable to owners of the parent company |
|
17,259 |
17,782 |
|
Non-controlling interest |
|
(1,380) |
(1,288) |
|
Total equity |
|
15,879 |
16,494 |
|
Liabilities |
|
|
|
|
Non-current liabilities |
|
|
|
|
Trade and other payables |
|
1,308 |
1,222 |
|
Deferred taxation |
|
67 |
67 |
|
Innovate Loan |
|
3,341 |
2,260 |
|
Long-term borrowings |
|
304 |
356 |
|
|
|
5,020 |
3,905 |
|
Current liabilities |
|
|
|
|
Trade and other payables |
|
3,162 |
3,748 |
|
Provisions |
|
119 |
119 |
|
Invoice discounting advances |
|
376 |
631 |
|
Current portion of long-term borrowings |
|
290 |
347 |
|
|
|
3,947 |
4,845 |
|
Total liabilities |
|
8,967 |
8,750 |
|
Total equity and liabilities |
|
24,846 |
25,244 |
Group statement of changes in equity
For the half year ended
|
|
Share capital £'000 |
Share premium account £'000 |
Merger reserve £'000 |
Share-based payment reserve £'000 |
Accumulated losses £'000 |
Non- controlling interest £'000 |
Total equity £'000 |
|
At |
1,697 |
25,497 |
1,256 |
2,056 |
(13,846) |
(999) |
15,661 |
|
Loss for the period |
- |
- |
- |
- |
(4,158) |
(181) |
(4,339) |
|
Share-based charge |
- |
- |
- |
597 |
- |
- |
597 |
|
At |
1,697 |
25,497 |
1,256 |
2,653 |
(18,004) |
(1,180) |
11,919 |
|
Issue of shares |
202 |
7,506 |
- |
- |
- |
- |
7,708 |
|
Loss for the period |
- |
- |
- |
- |
(3,621) |
(108) |
(3,729) |
|
Share-based payments |
- |
- |
- |
596 |
- |
- |
596 |
|
At |
1,899 |
33,003 |
1,256 |
3,249 |
(21,625) |
(1,288) |
16,494 |
|
Issue of shares |
42 |
1,861 |
- |
- |
- |
- |
1,903 |
|
Loss for the period |
- |
- |
- |
- |
(3,021) |
(92) |
(3,113) |
|
Share-based payments |
- |
- |
- |
595 |
- |
- |
595 |
|
At |
1,941 |
34,864 |
1,256 |
3,844 |
(24,646) |
(1,380) |
(15,879) |
Included within the merger reserve is
Statement of Group cash flows
For the half year ended
|
|
Six months ended 30 September 2021 Unaudited £'000 |
Six months ended 30 September 2020 Unaudited £'000 |
|
Cash flows from operating activities |
|
|
|
Cash used in operations |
(1,081) |
(683) |
|
Interest paid |
(107) |
(64) |
|
Net cash used in operating activities |
(1,188) |
(747) |
|
Cash flows from investing activities |
|
|
|
Purchase of intangible assets |
(853) |
(169) |
|
Purchase of property, plant and equipment |
(1,018) |
(1) |
|
Net cash used in investing activities |
(1,871) |
(170) |
|
Cash flows from financing activities |
|
|
|
Share issue |
1,926 |
- |
|
Share issue costs |
(23) |
- |
|
Principal payment of leases under IFRS 16 |
(386) |
(480) |
|
Innovate |
1,081 |
1,964 |
|
Net proceeds from CBIL loan |
25 |
- |
|
Funds received from Lanstead Sharing Agreement |
1,794 |
925 |
|
Net invoice discounting advances |
(255) |
(643) |
|
Net cash generated from financing activities |
4,162 |
1,766 |
|
Increase in cash and cash equivalents |
1,103 |
849 |
|
Cash and cash equivalents at start of period |
2,359 |
1,657 |
|
Cash and cash equivalents at end of period |
3,462 |
2,506 |
Note to the statement of Group cash flows
For the half year ended 30 September 2021
|
|
Six months ended 30 September 2021 Unaudited £'000 |
Six months ended 30 September 2020 Unaudited £'000 |
|
Loss before income tax |
(3,113) |
(4,339) |
|
Adjustments for: |
|
|
|
Share-based payments |
595 |
597 |
|
Depreciation and amortisation |
724 |
552 |
|
Disposal of non-current assets |
87 |
4 |
|
Finance cost |
107 |
64 |
|
Loss on FV movement of share agreement |
830 |
1,817 |
|
Decrease in inventories |
148 |
242 |
|
Decrease in trade and other receivables |
166 |
447 |
|
(Decrease) in trade and other payables |
(625) |
(67) |
|
Cash used in operations |
(1,081) |
(683) |
|
Discontinued operations |
Six months ended 30 September 2021 Unaudited £'000 |
Six months ended 30 September 2020 Unaudited £'000 |
|
Net cash generated/(used) in operating activities |
122 |
(7) |
|
Net cash used in investing activities |
(3) |
- |
|
Net cash generated/(used) from financing activities |
(118) |
15 |
|
Increase in cash and cash equivalents from discontinued operations |
1 |
8 |
Notes to the unaudited interim statements
For the half year ended
1. Basis of preparation
Versarien Plc is an AIM quoted company incorporated and domiciled in the
The interim financial statements were prepared by the Directors and approved for issue on
As permitted, these interim financial statements have been prepared in accordance with
These interim financial statements have been prepared on a going concern basis using similar assumptions to those made in the statutory accounts to
Certain statements within this report are forward looking. The expectations reflected in these statements are considered reasonable. However, no assurance can be given that they are correct. As these statements involve risks and uncertainties the actual results may differ materially from those expressed or implied by these statements. The interim financial statements have not been audited.
2. Discontinued operations
On 5 August, within the preliminary results, the Group announced its decision to exit the non-core aluminium business of Versarien Technologies Limited based in
the discontinued operation is set out below.
|
|
Notes |
Six months ended 30 September 2021 Unaudited £'000 |
Six months ended 30 September 2020 Unaudited £'000 |
|
|
|
|
|
|
Revenue |
3 |
451 |
408 |
|
Cost of sales |
|
(363) |
(297) |
|
Gross profit |
|
88 |
111 |
|
Other operating income |
|
1 |
2 |
|
Other losses |
|
- |
- |
|
Operating expenses (including exceptional items) |
|
(233) |
(134) |
|
Loss from operations before exceptional items |
|
(80) |
(21) |
|
Exceptional items |
4 |
(64) |
- |
|
Loss from operations |
|
(144) |
(21) |
|
Finance charge |
|
(11) |
(6) |
|
Loss before income tax |
|
(155) |
(27) |
|
Income Tax |
5 |
- |
- |
|
Loss from discontinued operations |
|
(155) |
(27) |
3. Segmental information
The segment analysis for the six months to
|
|
Central |
Technology Businesses |
Mature Businesses |
Discontinued Operations |
Intra-group Adjustments |
TOTAL |
|
|
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
|
|
|
|
|
|
|
|
|
Revenue |
- |
925 |
2,899 |
451 |
- |
4,275 |
|
Gross Margin |
- |
254 |
826 |
88 |
- |
1,168 |
|
Other gains/(losses) |
(830) |
- |
- |
- |
- |
(830) |
|
Other operating income |
- |
86 |
2 |
1 |
- |
89 |
|
Operating expenses |
(1,070) |
(1,379) |
(755) |
(233) |
4 |
(3,433) |
|
(Loss)/ profit from operations |
(1,900) |
(1,039) |
73 |
(144) |
4 |
(3,006) |
|
Finance income/(charge) |
(47) |
(13) |
(36) |
(11) |
- |
(107) |
|
(Loss)/profit before tax |
(1,947) |
(1,052) |
37 |
(155) |
4 |
(3,113) |
The segment analysis for the six months to
|
|
Central |
Technology Businesses |
Mature Businesses |
Discontinued Operations |
Intra-group Adjustments |
TOTAL |
|
|
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
|
|
|
|
|
|
|
|
|
Revenue |
- |
347 |
2,362 |
408 |
- |
3,117 |
|
Gross Margin |
- |
(71) |
470 |
111 |
- |
510 |
|
Other gains/(losses) |
(1,817) |
- |
- |
- |
- |
(1,817) |
|
Other operating income |
- |
70 |
2 |
2 |
- |
74 |
|
Operating expenses |
(1,191) |
(945) |
(763) |
(134) |
(9) |
(3,042) |
|
(Loss)/ profit from operations |
(3,008) |
(946) |
(291) |
(21) |
(9) |
(4,275) |
|
Finance income/(charge) |
(4) |
(22) |
(32) |
(6) |
- |
(64) |
|
(Loss)/profit before tax |
(3,012) |
(968) |
(323) |
(27) |
(9) |
(4,339) |
4. Exceptional items
|
|
Six months ended 30 September 2021 Unaudited £'000 |
Six months ended 30 September 2020 Unaudited £'000 |
|
Relocation and restructuring costs |
108 |
6 |
|
Costs relating to expansion in |
- |
70 |
|
Costs relating to setting up of the Korean subsidiary |
- |
6 |
|
Costs relating to asset purchase from Hanwha |
- |
85 |
|
Other |
- |
11 |
|
|
108 |
178 |
5. Taxation
The tax charge on the results for the period has been estimated at £nil (2020: £nil). At the last year end the Group had £19.4 million of trading losses carried forward to set-off against future trading profits.
6. Loss per share
The loss per share has been calculated by dividing the loss after taxation of
The calculation of the diluted earnings per share is based on the basic earnings per share adjusted to allow for the issue of shares on the assumed conversion of all dilutive options. However, in accordance with IAS33 "Earnings per Share", potential Ordinary shares are only considered dilutive when their conversion would decrease the profit per share or increase the loss per share. As at
7. Intangible assets
|
|
30 September 2021 Unaudited £'000 |
31 March 2021 Audited £'000 |
|
Goodwill |
3,555 |
3,555 |
|
Customer relationships/order books |
14 |
27 |
|
Development costs |
3,297 |
2,453 |
|
Licence |
51 |
58 |
|
Intellectual property |
3,480 |
3,613 |
|
Total |
10,397 |
9,706 |
8. Dividends
As stated in the 2013 AIM Admission document, the Board's objective is to continue to grow the Group's business and it is expected that any surplus cash resources will, in the short to medium term, be re-invested into the research and development of the Group's products. In view of this, no dividend is declared and the Directors will not be recommending a dividend for the foreseeable future. However, the Board intends that the Company will recommend or declare dividends at some future date once they consider it commercially prudent for the Company to do so, bearing in mind its financial position and the capital resources required for its development.
9. Interim Report
This interim announcement is available on the Group's website at www.versarien.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE